Summary:
We decreased to 32.8 U/ml, 10 U/ml, respectively. At 4 months after the therapy, the serum CA 19-9 level was 32.1 U/ml, but serum CA 72-4 level increased to 49 U/ml. At 7 months after the therapy, the patient eventually died of liver and brain metastasis.
DISCUSSION
The prognosis of gastric cancer with liver metastasis is very poor. Many cases of gastric cancerwith liver metastasis have multiple metastatic tumors in the liver. Even if metastatic liver tumors seemed to be resectable on CT or on intraoperative findings, many cases also have many micrometastases in the liver. Ushijima et al. [6] reported that the average survival period from multiple liver metastasis in the bilateral lobes was only 4.2 months. Recently, intrahepatic arterial infusion has been performed, using 5-FU, adriamycin (ADM), MMC, and cisplatin (CDDP) [3] [4] [5] 7, 8] . There are several case reports that the metastatic lesions in the liver disappeared andthe patient survived for a longer period [3] [4] [5] 7, 8] . Aoki [9] reported that intra-hepatic arterial infusion of an anti-cancer drug was better than systemic administration for treating the liver metastasis. In our case, multiple metastatic liver tumors had disappeared on CT at 14 weeks after commencing the intra-hepatic arterial infusion of 5-FU and MMC, but lymph node recurrence was recognized. At 7 months after the therapy, the patient eventually died of liver and brain metastasis. Nakagawa et al. [4] reported that three cases of gastric cancer with multiple liver metastases were treated with intra-hepatic arterial infusion of low-dosage CDDP and oral administration of highdosage 5'-DFUR after surgery, and all per lived more than one year, but there has been no case responsive to intra-hepatic arterial infusion of 5-FU alone. Arai et al. [l0] reported that the efficacy of intra-hepatic arterial infusion of a combination of 5-FU, ADM and MMC was high, but intra-hepatic arterial infusion of MMC and 5-FU has shown no response. However in our case, the multiple metastatic liver tumors disappeared after intra-hepatic arterial infusion of 5-FU and MMC. So, we need to perform intra-hepatic arterial infusion using a new prolonged regimen to treat the liver metastasis.
